Aflac Inc
- Market cap
- 56.52B
- P/E (TTM)i
- 12.16
- P/Bi
- 1.86
- EPSi
- 6.82
- Div yieldi
- 2.11%
- 52W posi
- 36%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 57.26-108.55, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is +36.0% above the average-multiple fair value of 82.90.
Valuation each multiple against its own 5-year range
Vs. peers Insurance - Life
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Aflac Inc (AFL) | 56.52B | 12.16 | 1.86 | 2.11% |
| Manulife Financial (MFC) | 68.93B | 16.10 | 2.11 | 3.13% |
| MetLife (MET) | 60.87B | 18.35 | 2.22 | 2.40% |
| Prudential Financial (PRU) | 38.76B | 10.19 | 1.23 | 4.89% |
| Prudential (PUK) | 29.39B | 8.28 | 1.48 | 2.26% |
| Unum Group (UNM) | 14.75B | 21.62 | 1.36 | 1.97% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 6.6% below Morningstar's fair value estimate.
Fair value
Aflac Inc receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% discount to our quantitative fair value estimate of $120.18 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
The firm's valuation metrics increase our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's enterprise value to market value ratio of 1.3 ranks in the top 40% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. We believe this is a sign that shares could be undervalued.
On a different note, the company's lack of growth is potentially concerning. Stagnant revenue and earnings growth indicates a company's challenges in increasing market share and profitability. The firm's revenue 5-year growth of -5.3%, for example, ranks in the bottom 20% compared with global peers. Weak trailing five-year revenue growth is disappointing and could indicate trouble generating future value for shareholders, which, despite our favorable price/fair value ratio, is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.
By Quantitative Equity Report
Quote time 2026-10-08 06:08:34 · For reference only, not investment advice and not tailored to your situation.